Evaluation of Tnf-α and Il-۶ mRNAs expressions in visceral and subcutaneous adipose tissues of polycystic ovarian rats and effects of resveratrol
محل انتشار: مجله علوم پایه پزشکی ایران، دوره: 21، شماره: 2
سال انتشار: 1397
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 156
فایل این مقاله در 10 صفحه با فرمت PDF قابل دریافت می باشد
- صدور گواهی نمایه سازی
- من نویسنده این مقاله هستم
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
JR_IJBMS-21-2_008
تاریخ نمایه سازی: 27 مهر 1400
چکیده مقاله:
Objective(s): Some studies suggest that chronic low-grade inflammation is involved in insulin resistance in polycystic ovary syndrome (PCOS). This study assessed possible involvement of alteration in expression of two pro-inflammatory factors, tumor necrosis factor-α (TNF-α) and interleukin-۶ (IL-۶) in adipose tissues of PCOS rats in the impairment of insulin actions. Also, effects of resveratrol as an anti-inflammatory agent were investigated. Materials and Methods: Fifteen female Wistar rats (۲۱ days old) were divided into three groups (n=۵): Ι) Control, П) PCO-model-saline: served as PCOS rats and to induce PCOS, received subcutaneously testosterone enanthate ۱ mg/۱۰۰ g body weight subcutaneously for ۳۵ days, Ш) PCO-model-resveratrol, after receiving testosterone, received resveratrol ۱۰ mg/kg intraperitoneally for ۲۸ days. The expression of Tnf-α and Il-۶ mRNAs in adipose tissues was determined by the qRT-PCR method. Results: The Il-۶ mRNA expression in the visceral adipose tissue of PCOS rats was increased in comparison to controls (P<۰.۰۵). Tnf-α and Il-۶ mRNA expression in visceral and subcutaneous adipose tissues of polycystic ovarian rats was similar to controls. The expression of Tnf-α mRNA in subcutaneous adipose tissue and Tnf-α and Il-۶ mRNAs in the visceral adipose tissue of the PCO-model-resveratrol group were lower than PCOS rats (P<۰.۰۵). Conclusion: Increased expression of Il-۶ mRNA in the visceral adipose tissue of polycystic ovarian rats may be one cause of insulin resistance observed in them and resveratrol as an anti-inflammatory and anti-hyperglycemic agent may decrease the risk of diabetes by reduction of expression of pro-inflammatory cytokines TNF-α and IL-۶ in PCOS patients.
کلیدواژه ها:
نویسندگان
Mahnaz Ghowsi
Department of Physiology, Faculty of Biological Sciences and Technology, Shahid Beheshti University, Tehran, Iran
Homayoun Khazali
Department of Physiology, Faculty of Biological Sciences and Technology, Shahid Beheshti University, Tehran, Iran
Sajjad Sisakhtnezhad
Department of Biology, Faculty of Sciences, Razi University, Kermanshah, Iran
مراجع و منابع این مقاله:
لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :